HPV and Male Homosexuality in General Practice?

The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination.

The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Papilloma Viral Infection Communicable Diseases DNA Virus Infections Disease Attributes Genital Diseases Infections Papillomavirus Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Tumor Virus Infections Urogenital Diseases Virus Diseases

Age range

18 year–26 year

Sex eligibility

Male

Study type

Observational

Primary location

Service du Trait d'Union - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age: 18-26 years
Consultation at the HUS Cegidd as part of an STI screening
Subject who expressed no opposition to participating in the study

Exclusion criteria

Refusal of the patient to participate in the study
Subject who had already benefited from HPV vaccination (at least one dose)
Inability to give informed consent
Subject under safeguarde of justice
Subject under guardianship or under curatorship

Treatment and study plan

Primary outcomes

Retrospective descriptive study of vaccination against HPV (Human Papilloma Virus) in Alsace?

Time frame: Files analysed retrospectively from April 27, 2021 to January 27, 2020 will be examined]

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

HPV Vaccination (Human Papilloma Virus), or How to Address Male Homosexuality in General Practice in Alsace?

Acronym: HPV

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Oct 14, 2021
Registry last updated: Sep 10, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed